Literature DB >> 16099902

In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus.

C A L Oura1, M S Denyer1, H Takamatsu1, R M E Parkhouse1.   

Abstract

To understand the mechanisms involved in protective immunity to African swine fever virus (ASFV) infection, the observation that infection with the avirulent Portuguese ASFV isolate OUR/T88/3 protects outbred pigs from challenge with the virulent Portuguese ASFV isolate OUR/T88/1 was exploited. It was demonstrated that pigs exposed to OUR/T88/3 and then depleted of CD8+ lymphocytes were no longer fully protected from OUR/T88/1 challenge. This indicated that CD8+ lymphocytes play an important role in the protective immune response to ASFV infection and that anti-ASFV antibody alone, from OUR/T88/3 infection, was not sufficient to protect pigs from OUR/T88/1 challenge. Inbred pigs of the cc haplotype infected with OUR/T88/3 were not always protected from OUR/T88/1 challenge and developed both viraemia and fever. Such viraemia was always correlated with increased numbers of circulating CD8beta+ lymphocytes, indicating a specific role for CD8beta+ lymphocytes in combating viraemia. These experiments indicate an important role for CD8+ lymphocytes, particularly CD8beta+ lymphocytes, in ASF protective immunity.

Entities:  

Mesh:

Year:  2005        PMID: 16099902     DOI: 10.1099/vir.0.81038-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  72 in total

1.  Simultaneous Deletion of the 9GL and UK Genes from the African Swine Fever Virus Georgia 2007 Isolate Offers Increased Safety and Protection against Homologous Challenge.

Authors:  Vivian O'Donnell; Guillermo R Risatti; Lauren G Holinka; Peter W Krug; Jolene Carlson; Lauro Velazquez-Salinas; Paul A Azzinaro; Douglas P Gladue; Manuel V Borca
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

2.  Enhanced Efficacy of Immunization with a Foot-and-Mouth Disease Multi-Epitope Subunit Vaccine Using Mannan-Decorated Inulin Microparticles.

Authors:  So-Yeon Yoon; Sang-Kee Kang; Ho-Bin Lee; Seo-Ho Oh; Whee-Soo Kim; Hui-Shan Li; Jin-Duck Bok; Chong-Su Cho; Yun-Jaie Choi
Journal:  Tissue Eng Regen Med       Date:  2019-12-09       Impact factor: 4.169

3.  Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice.

Authors:  Xinxin Chen; Jifei Yang; Yanhong Ji; Edward Okoth; Bin Liu; Xiaoyang Li; Hong Yin; Qiyun Zhu
Journal:  Virol Sin       Date:  2016-03-11       Impact factor: 4.327

4.  African Swine Fever Virus Georgia 2007 with a Deletion of Virulence-Associated Gene 9GL (B119L), when Administered at Low Doses, Leads to Virus Attenuation in Swine and Induces an Effective Protection against Homologous Challenge.

Authors:  Vivian O'Donnell; Lauren G Holinka; Peter W Krug; Douglas P Gladue; Jolene Carlson; Brenton Sanford; Marialexia Alfano; Edward Kramer; Zhiqiang Lu; Jonathan Arzt; Bo Reese; Consuelo Carrillo; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens.

Authors:  Shehnaz Lokhandwala; Suryakant D Waghela; Jocelyn Bray; Cameron L Martin; Neha Sangewar; Chloe Charendoff; Rashmi Shetti; Clay Ashley; Chang-Hsin Chen; Luc R Berghman; Duncan Mwangi; Paul J Dominowski; Dennis L Foss; Sharath Rai; Shaunak Vora; Lindsay Gabbert; Thomas G Burrage; David Brake; John Neilan; Waithaka Mwangi
Journal:  Clin Vaccine Immunol       Date:  2016-11-04

6.  Porcine Immunoglobulin Fc Fused P30/P54 Protein of African Swine Fever Virus Displaying on Surface of S. cerevisiae Elicit Strong Antibody Production in Swine.

Authors:  Chen Chen; Deping Hua; Jingxuan Shi; Zheng Tan; Min Zhu; Kun Tan; Lilin Zhang; Jinhai Huang
Journal:  Virol Sin       Date:  2020-09-11       Impact factor: 4.327

7.  Recombinant antigen targets for serodiagnosis of African swine fever.

Authors:  Carmina Gallardo; Ana Luísa Reis; Gladys Kalema-Zikusoka; Joana Malta; Alejandro Soler; Esther Blanco; R M E Parkhouse; Alexandre Leitão
Journal:  Clin Vaccine Immunol       Date:  2009-05-06

8.  Expression library immunization can confer protection against lethal challenge with African swine fever virus.

Authors:  Anna Lacasta; María Ballester; Paula L Monteagudo; Javier M Rodríguez; María L Salas; Francesc Accensi; Sonia Pina-Pedrero; Albert Bensaid; Jordi Argilaguet; Sergio López-Soria; Evelyne Hutet; Marie Frédérique Le Potier; Fernando Rodríguez
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

9.  Polymorphism analysis and supertype definition of swine leukocyte antigen class I molecules in three-way crossbred (Landrace, Duroc, and Yorkshire) pigs: implications for the vaccine development of African swine fever virus.

Authors:  Limin Ba; Zhenbao Wang; William J Liu; Dongxun Wu; Wangzhen Xiang; Peng Qi; Chunna Dong; Yanxin Hu; Ping Lu; Jin Xiao; Changyuan Yu
Journal:  Sci China Life Sci       Date:  2020-05-11       Impact factor: 6.038

10.  The low-virulent African swine fever virus (ASFV/NH/P68) induces enhanced expression and production of relevant regulatory cytokines (IFNalpha, TNFalpha and IL12p40) on porcine macrophages in comparison to the highly virulent ASFV/L60.

Authors:  S Gil; N Sepúlveda; E Albina; A Leitão; C Martins
Journal:  Arch Virol       Date:  2008-09-12       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.